| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner
4 companies
Tammenoms Bakker Juliet is a Director, 10% Owner at VERO with holdings across 4 companies. Recent SEC Form 4 filings include 8 buys and 10 sells.
Estimated insider holdings value: $8.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | CBLL Ceribell, Inc. | Director | Buy | 237,234 | $17.00 | $4,032,978.00 | +10.6% | -18.4% | -50.5% | |
| May 17, 2024 | RXST Rxsight, Inc. | Director | Buy | 5,000 | $61.09 | $305,456.50 | +16.8% | -16.3% | -76.6% | |
| Feb 14, 2024 | RXST Rxsight, Inc. | Director | Buy | 8,000 | $50.83 | $406,672.80 | +16.8% | +15.6% | -38.8% | |
| Nov 29, 2023 | RXST Rxsight, Inc. | Director | Sell | 494,313 | $29.73 | $14,695,695.32 | -58.6% | +94.5% | +57.4% | |
| Nov 15, 2023 | RXST Rxsight, Inc. | Director | Sell | 500,000 | $27.18 | $13,590,750.00 | -26.5% | +84.2% | +60.8% | |
| Sep 11, 2023 | RXST Rxsight, Inc. | Director | Sell | 32,950 | $30.14 | $992,968.65 | -30.1% | +16.2% | +77.3% | |
| Aug 25, 2023 | RXST Rxsight, Inc. | Director | Sell | 16,208 | $29.25 | $474,129.38 | -23.4% | -0.4% | +91.4% | |
| Aug 18, 2023 | RXST Rxsight, Inc. | Director | Sell | 33,135 | $29.62 | $981,570.47 | -17.9% | -6.1% | +76.1% | |
| Feb 10, 2023 | RXST Rxsight, Inc. | Director | Buy | 480,000 | $12.50 | $6,000,000.00 | +96.0% | +71.4% | +288.2% | |
| Aug 3, 2021 | RXST Rxsight, Inc. | Director | Buy | 637,500 | $16.00 | $10,200,000.00 | +34.1% | -28.2% | -8.6% |